ID

18446

Descripción

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00359112

Link

https://clinicaltrials.gov/show/NCT00359112

Palabras clave

  1. 5/11/16 5/11/16 -
Subido en

5 de noviembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-Insulin-Dependent Diabetes Mellitus NCT00359112

Eligibility Non-Insulin-Dependent Diabetes Mellitus NCT00359112

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
body mass index > or = to 25 kg/m2.
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
hba1c > or =7% and < or =10% at screening.
Descripción

Glycosylated hemoglobin A

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019018
fpg > or = 7.0mmol/l (126mg/dl) at visit 2.
Descripción

Plasma fasting glucose measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0583513
receiving at least 0.85g of metformin at constant dose(s) for at least 8 weeks prior to visit 1a.
Descripción

Metformin Dose Constant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C1948059
female subjects must be postmenopausal or using effective contraceptive measures.
Descripción

Gender Contraceptive methods | Postmenopausal state

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C0232970
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of any other oral antidiabetic drug other than metformin within 12 weeks prior to screening.
Descripción

Antidiabetics Oral | Metformin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C0025598
subjects with clinically significant ongoing oedema requiring pharmacological treatment or with a history of oedema requiring pharmacological treatment.
Descripción

Edema Clinical Significance Requirement Pharmacotherapy | Edema Requirement Pharmacotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013604
UMLS CUI [1,2]
C2826293
UMLS CUI [1,3]
C1514873
UMLS CUI [1,4]
C0013216
UMLS CUI [2,1]
C0013604
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0013216
subjects with a history of severe hypoglycaemia.
Descripción

Hypoglycemia Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
renal disease or renal dysfunction.
Descripción

Kidney Disease | Renal dysfunction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2]
C3279454
presence of clinically significant hepatic disease.
Descripción

Liver disease Clinical Significance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C2826293
presence of unstable or severe angina or known nyha grade i-iv congestive heart failure.
Descripción

Angina, Unstable | Angina Pectoris Severe | Congestive heart failure | New York Heart Association Classification

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2,1]
C0002962
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0018802
UMLS CUI [4]
C1275491
subjects who have had a previous myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass graft or cerebrovascular accident within 3 months prior to screening.
Descripción

Myocardial Infarction | Percutaneous Transluminal Coronary Angioplasty | Coronary Artery Bypass Surgery | Cerebrovascular accident

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C2936173
UMLS CUI [3]
C0010055
UMLS CUI [4]
C0038454

Similar models

Eligibility Non-Insulin-Dependent Diabetes Mellitus NCT00359112

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Body mass index
Item
body mass index > or = to 25 kg/m2.
boolean
C1305855 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c > or =7% and < or =10% at screening.
boolean
C0019018 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fpg > or = 7.0mmol/l (126mg/dl) at visit 2.
boolean
C0583513 (UMLS CUI [1])
Metformin Dose Constant
Item
receiving at least 0.85g of metformin at constant dose(s) for at least 8 weeks prior to visit 1a.
boolean
C0025598 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1948059 (UMLS CUI [1,3])
Gender Contraceptive methods | Postmenopausal state
Item
female subjects must be postmenopausal or using effective contraceptive measures.
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0232970 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Antidiabetics Oral | Metformin
Item
use of any other oral antidiabetic drug other than metformin within 12 weeks prior to screening.
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0025598 (UMLS CUI [2])
Edema Clinical Significance Requirement Pharmacotherapy | Edema Requirement Pharmacotherapy
Item
subjects with clinically significant ongoing oedema requiring pharmacological treatment or with a history of oedema requiring pharmacological treatment.
boolean
C0013604 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0013216 (UMLS CUI [1,4])
C0013604 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0013216 (UMLS CUI [2,3])
Hypoglycemia Severe
Item
subjects with a history of severe hypoglycaemia.
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Kidney Disease | Renal dysfunction
Item
renal disease or renal dysfunction.
boolean
C0022658 (UMLS CUI [1])
C3279454 (UMLS CUI [2])
Liver disease Clinical Significance
Item
presence of clinically significant hepatic disease.
boolean
C0023895 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Angina, Unstable | Angina Pectoris Severe | Congestive heart failure | New York Heart Association Classification
Item
presence of unstable or severe angina or known nyha grade i-iv congestive heart failure.
boolean
C0002965 (UMLS CUI [1])
C0002962 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0018802 (UMLS CUI [3])
C1275491 (UMLS CUI [4])
Myocardial Infarction | Percutaneous Transluminal Coronary Angioplasty | Coronary Artery Bypass Surgery | Cerebrovascular accident
Item
subjects who have had a previous myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass graft or cerebrovascular accident within 3 months prior to screening.
boolean
C0027051 (UMLS CUI [1])
C2936173 (UMLS CUI [2])
C0010055 (UMLS CUI [3])
C0038454 (UMLS CUI [4])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial